Economic analysis of the 1992–1993 mass immunization campaign against serogroup C meningococcal disease in Quebec
- 19 March 2002
- Vol. 20 (21-22) , 2840-2844
- https://doi.org/10.1016/s0264-410x(02)00161-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec.JAMA, 2001
- Cost-utility analyses of clinical preventive services11The full text of this article is available via AJPM Online at http://www.elsevier.com/locate/ajpmonline.American Journal of Preventive Medicine, 2000
- Mucosal Immune Responses to Meningococcal Group C Conjugate and Group A and C Polysaccharide Vaccines in AdolescentsInfection and Immunity, 2000
- Complications and Sequelae of Meningococcal Disease in Quebec, Canada, 1990–1994Clinical Infectious Diseases, 1998
- A benefit-cost analysis of two-dose measles immunization in CanadaVaccine, 1998
- Are Proxy Assessments of Health Status After Stroke With the EuroQol Questionnaire Feasible, Accurate, and Unbiased?Stroke, 1997
- The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidisJAMA, 1995
- Prevention of Meningococcal Disease by Group C Polysaccharide VaccineNew England Journal of Medicine, 1970
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969
- HUMAN IMMUNITY TO THE MENINGOCOCCUSThe Journal of Experimental Medicine, 1969